Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Cancer Immunology Research|January 9, 2025
TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor SpheroidsYi Sun, Luke Maggs, Apekshya Panda, et al.Biorxiv : the Preprint Server for Biology|December 3, 2025
Lymphotoxin-driven cancer cell eradication by tumoricidal CD8+ TILHongyan Xie, Aiping Jiang, Aonkon Dey, et al.Biorxiv : the Preprint Server for Biology|February 26, 2024
Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapyOr-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.Cell Reports. Medicine|June 27, 2025
Overcoming resistance to immunotherapy by targeting CD38 in human tumor explantsOr-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.Nature|January 12, 2023
Targeting TBK1 to overcome resistance to cancer immunotherapyYi Sun, Or-Yam Revach, Seth Anderson, et al.Pageof 1